1. Topical beta‐blockers in dermatologic therapy
   Angela Filoni et al, 2021, Dermatologic Therapy CrossRef
2. Plant-derived phenolic acids in the treatment of pulmonary hypertension: A review of the underlying mechanisms
   Elaheh Mirhadi et al, 2024, PharmaNutrition CrossRef
3. Osthole Attenuates Macrophage Activation in Experimental Asthma by Inhibitingthe NF-ĸB/MIF Signaling Pathway
   Ruyi Li et al, 2021, Frontiers in Pharmacology CrossRef
4. Angiotensin‑converting enzyme 2 alleviates pulmonary artery hypertension through inhibition of focal adhesion kinase expression
   Rui Wang et al, 2021, Experimental and Therapeutic Medicine CrossRef
5. Characteristics of the right atrial and right ventricular contractility in a model of monocrotaline-induced pulmonary arterial hypertension
   Oksana P. Gerzen et al, 2023, Journal of Muscle Research and Cell Motility CrossRef
6. Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
   Zhifeng Xue et al, 2021, Frontiers in Pharmacology CrossRef
7. An Overview on Sources, Biosynthesis and Bioactivities of Osthole: A Potential Bioactive Compound
   Gurdeep Singh et al, 2023, Current Bioactive Compounds CrossRef
8. Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells
   Yun Yue et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222
   Han Wang et al, 2020, Shock CrossRef
10. The Role of Systemic and Topical Beta-Blockers in Dermatology: A Systematic Review
    Alya M. Alhazmi et al, 2023, Dermatology and Therapy CrossRef
11. Osthole Regulates Secretion of Pro-Inflammatory Cytokines and Expression of TLR2 and NF-κB in Normal Human Keratinocytes and Fibroblasts
    Natalia Kordulewska et al, 2022, Journal of Inflammation Research CrossRef
12. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives
    Wei Zheng et al, 2020, Journal of Medicinal Chemistry CrossRef
13. A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea
    Danfeng Wei et al, 2021, Journal of Cosmetic Dermatology CrossRef
14. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats
    Chao Tang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
15. Effects of Crocin on CCL2/CCR2 Inflammatory Pathway in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats
    Yanling Sheng et al, 2022, The American Journal of Chinese Medicine CrossRef
16. Clinical and morphological features of necrobiosis lipoidica
    Kevin J. Severson et al, 2022, Journal of the American Academy of Dermatology CrossRef
17. Osthole improves pulmonary artery hypertension by inducing apoptosis in pulmonary artery smooth muscle cells
    Ling Zhu et al, 2021, Journal of Pharmacy and Pharmacology CrossRef
18. Cold exposure aggravates pulmonary arterial hypertension through increased miR-146a-5p, miR-155-5p and cytokines TNF-α, IL-1β, and IL-6
    José L. Sánchez-Gloria et al, 2021, Life Sciences CrossRef
19. Effects of Osthol Isolated from Cnidium monnieri Fruit on Urate Transporter 1
    Yuusuke Tashiro et al, 2018, Molecules CrossRef
20. Natural ingredients from Chinese materia medica for pulmonary hypertension
    Jia-Rui ZHANG et al, 2021, Chinese Journal of Natural Medicines CrossRef
21. Braylin induces a potent vasorelaxation, involving distinct mechanisms in superior mesenteric and iliac arteries of rats
    W. A. Santos et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
22. Anti-Inflammatory Effect of Allicin Associated with Fibrosis in Pulmonary Arterial Hypertension
    José L. Sánchez-Gloria et al, 2021, International Journal of Molecular Sciences CrossRef